Weiterbildungsbefugnisse

  • Urologie / FA Urologie / 60 Monate / LÄK Bayern / /

Kurzvita

Höhepunkte der beruflichen Laufbahn

  • 2004 AIP, Assistenz- und Facharzt - Klinik und Poliklinik für Urologie der Universität Regensburg, Caritas Krankenhaus St. Josef (Direktor Prof. Dr. W.F. Wieland)
  • 2011 Oberarzt - Klinik und Poliklinik für Urologie der Universität Regensburg, Caritas Krankenhaus St. Josef
  • 2014 Stellvertretender Klinikdirektor - Klinik und Poliklinik für Urologie der Universität Leipzig (Direktor Prof. Dr. J.-U. Stolzenburg)
  • 2017 Chefarzt – Klinik für Urologie, Asklepios Stadtklinik Bad Tölz

Mitgliedschaften in medizinischen Fachgesellschaften

  • American Association of Urology (AUA)
  • Arbeitskreis „Fokale und Mikrotherapie“ der DGU
  • Deutsche Gesellschaft für Urologie (DGU)
  • EAU Section of Uro-Technology (ESUT) – Ablative group
  • European Association of Urology (EAU)

Forschung & Lehre

Forschungsschwerpunkte

  • Anatomie des unteren Harntraktes
  • Fokale Therapie des Prostatakarzinoms

Weitere Publikationen

  • Ganzer R, Neuhaus J, Dorschner W, Stolzenburg JU. Muscle systems of the lower urinary tract of the male rhesus monkey (Macaca mulatta): histomorphology and 3-dimensional reconstruction. J Urol. 2002 Oct;168(4 Pt 1):1603-7.
  • Ganzer R, Köhler D, Neuhaus J, Dorschner W, Stolzenburg JU. Is the rhesus monkey (Macaca mulatta) comparable to humans? Histomorphology of the sphincteric musculature of the lower urinary tract including 3D-reconstruction. Anat Histol Embryol. 2004 Dec;33(6):355-61.
  • Stolzenburg JU, Neuhaus J, Liatsikos EN, Schwalenberg T, Ludewig E, Ganzer R. Histomorphology of canine urethral sphincter systems, including three-dimensional reconstruction and magnetic resonance imaging. Urology. 2006 Mar;67(3):624-30.
  • Blana A, Rogenhofer S, Ganzer R, Wild PJ, Wieland WF, Walter B. Morbidity associated with repeated transrectal high-intensity focused ultrasound treatment of localized prostate cancer. World J Urol. 2006 Nov;24(5):585-90.
  • Ganzer R, Denzinger S, Fink A, Wieland WF, Blana A. Open partial nephrectomy for imperative and elective indications: comparison of peri-operative data and long-term follow-up. Scand J Urol Nephrol. 2007;41(6):496-500.
  • Ganzer R, Wieland WF, Bach T, Rössler W, Blana A. [Hormonal treatment of cancer of the prostate: review and present status] Dtsch Med Wochenschr. 2007 Jan 26;132(4):161-6. Review.
  • Denzinger S, Burger M, Hartmann A, Hofstaedter F, Wieland WF, Ganzer R. Spontaneous rupture of a benign giant adrenal adenoma. APMIS. 2007 Apr;115(4):381-4.
  • Blana A, Denzinger S, Lenhart M, Wieland WF, Ganzer R. Treatment of a recurrent inguinal lymphocele in a penis cancer patient by lymphography and selective ligation of lymphatic vessels. Int J Urol. 2007 May;14(5):450-1.
  • Bach T, Herrmann TR, Ganzer R, Burchardt M, Gross AJ. RevoLix vaporesection of the prostate: initial results of 54 patients with a 1-year follow-up. World J Urol. 2007 Jun;25(3):257-62.
  • Blana A, Straub M, Wild PJ, Lunz JC, Bach T, Wieland WF, Ganzer R. Approach to endoscopic extraperitoneal radical prostatectomy (EERPE): the impact of previous laparoscopic experience on the learning curve. BMC Urol. 2007 Jul 9;7:11.
  • Ganzer R, Rogenhofer S, Walter B, Lunz JC, Schostak M, Wieland WF, Blana A. PSA nadir is a significant predictor of treatment failure after high-intensity focussed ultrasound (HIFU) treatment of localised prostate cancer. Eur Urol. 2008 Mar;53(3):547-53. Epub 2007 Jul 17.
  • Ganzer R, Burger M, Woenckhaus M, Wieland WF, Blana A. A patient with testicular pseudolymphoma - a rare condition mimicking malignancy: a case report. J Med Case Reports. 2007 Aug 25;1(1):71.
  • Denzinger S, Burger M, Fritsche HM, Ganzer R, Blana A, Wieland WF, Otto W. [Bladder preservation or initial cystectomy in T1G3 bladder cancer: which parameters help in therapeutic decision-making?] Aktuelle Urol. 2008 Jan;39(1):58-61; discussion 62-3.
  • Ganzer R, Blana A, Gaumann A, Stolzenburg JU, Rabenalt R, Bach T, Wieland WF, Denzinger S.Topographical anatomy of periprostatic and capsular nerves: quantification and computerised planimetry. Eur Urol. 2008 Aug;54(2):353-61. Epub 2008 Apr 15.
  • Blana A, Hierl J, Rogenhofer S, Lunz JC, Wieland WF, Walter B, Bach T, Ganzer R. Factors predicting for formation of bladder outlet obstruction after high-intensity focused ultrasound in treatment of localized prostate cancer. Urology. 2008 May;71(5):863-867.
  • Fritsche HM, Burger M, Ganzer R, Otto W, Denzinger S, Wieland WF. [Impact of comorbidity on perioperative mortality after radical cystectomy] Aktuelle Urol. 2008 May;39(3):225-8.
  • Ganzer R, Wieland WF, Stolzenburg JU. Reply to Declan G. Murphy, Ben Dowdle and Anthony J Costello's Letter to the Editor re: Roman Ganzer, Andreas Blana, Andreas Gaumann, et al. Topographical Anatomy of Periprostatic and Capsular Nerves: Quantification and Computerised Planimetry. Eur Urol 2008;54:353-61. Oct 9.
  • Blana A, Rogenhofer S, Ganzer R, Lunz JC, Schostak M, Wieland WF, Walter B. Eight years' experience with high-intensity focused ultrasonography for treatment of localized prostate cancer. Urology. 2008 Dec;72(6):1329-33; discussion 1333-4.
  • Liatsikos E, Rabenalt R, Burchardt M, Backhaus MR, Do M, Dietel A, Wasserscheid J, Constantinides C, Kallidonis P, Truss MC, Herrmann TR, Ganzer R, Stolzenburg JU. Prevention and management of perioperative complications in laparoscopic and endoscopic radical prostatectomy. World J Urol. 2008 Dec;26(6):571-80.
  • Stolzenburg JU, Wasserscheid J, Rabenalt R, Do M, Schwalenberg T, McNeill A, Constantinides C, Kallidonis P, Ganzer R, Liatsikos E. Reduction in incidence of lymphocele following extraperitoneal radical prostatectomy and pelvic lymph node dissection by bilateral peritoneal fenestration. World J Urol. 2008 Dec;26(6):581-6.
  • Blana A, Brown SC, Chaussy C, Conti GN, Eastham JA, Ganzer R, Murat FJ, Pasticier G, Rebillard X, Rewcastle JC, Robertson CN, Thuroff S, Ward JF. High-intensity focused ultrasound for prostate cancer: comparative definitions of biochemical failure. BJU Int. 2009 Apr 17.
  • Ramírez-Backhaus M, Rabenalt R, Jain S, Do M, Liatsikos E, Ganzer R, Horn LC, Burchardt M, Jiménez-Cruz F, Stolzenburg JU. Value of frozen section biopsies during radical prostatectomy: significance of the histological results. World J Urol. 2009 Apr;27(2):227-34.
  • Bach T, Herrmann TR, Ganzer R, Blana A, Burchardt M, Gross AJ. [Thulium:YAG vaporesection of the prostate. First results]. Urologe A. 2009 May;48(5):529-34.
  • Fritsche HM, Ganzer R, Schlaier J, Wieland WF, Brawanski A, Lange M. Acute urinary retention in two patients after subthalamic nucleus deep brain stimulation (STN-DBS) for the treatment of advanced Parkinson's disease. Mov Disord. 2009 May 13;24(10):1553-1554
  • Fritsche HM, Ganzer R, Schlaier J, Wieland WF, Brawanski A, Lange M. Acute urinary retention in two patients after subthalamic nucleus deep brain stimulation (STN-DBS) for the treatment of advanced Parkinson's disease. Mov Disord. 2009 May 13;24(10):1553-1554
  • Adam C, Salomon G, Walther S, Zaak D, Khoder W, Becker A, Reich O, Blana A, Ganzer R, Denzinger S, Popken G, Sroka R, Knüchel-Clarke R, Köllermann J, Sauter G, Hartmann A, Bertz S, Graefen M, Huland H, Wieland W, Stief CG. Photodynamic diagnosis using 5-aminolevulinic acid for the detection of positive surgical margins during radical prostatectomy in patients with carcinoma of the prostate: A Multicentre, Prospective, Phase 2 Trial of a Diagnostic Procedure. Eur Urol. 2009 Jun; 55(6):1281-1288.
  • Ganzer R, Rabenalt R, Truss MC, Papadoukakis S, Do M, Blana A, Straub M, Denzinger S, Wieland WF, Burchardt M, Herrmann T, Stolzenburg JU. Evaluation of complications in endoscopic extraperitoneal radical prostatectomy in a modular training programme: a multicentre experience. World J Urol. 2008 Dec;26(6):587-93. Epub 2008 Jul 16.
  • Ganzer R, Blana A, Stolzenburg JU, Rabenalt R, Fritsche HM, Wieland WF, Denzinger S. Nerve quantification and computerized planimetry to evaluate periprostatic nerve distribution – does size matter? Urology. 2009 Aug;74(2):398-403.
  • Ganzer R, Neuhaus J, Gratzke C, Blana A, Wieland WF, Stolzenburg JU. Anatomical description of the periprostatic nerves in the male rhesus monkey (Macaca mulatta). World J Urol. 2009 Sep 16.
  • Schlenker B, Seitz M, Bader MJ, Ganzer R, Tilki D, Bayrle F, Reich O, Staehler M, Bachmann A, Stief CG, Gratzke C. Comparison of guideline recommendations with daily practice in patients with renal cell carcinoma. Eur J Med Res. 2010 Jun 28;15(6):253-7.
  • Stolzenburg JU, Kallidonis P, Do M, Dietel A, Häfner T, Rabenalt R, Sakellaropoulos G, Ganzer R, Paasch U, Horn LC, Liatsikos E. A comparison of outcomes for interfascial and intrafascial nerve-sparing radical prostatectomy. Urology. 2010 Sep;76(3):743-8.
  • Ganzer R, Blana A. Do we have enough evidence to recommend the routine use of High-Intensity Focussed Ultrasound for the primary and salvage treatment of prostate cancer? Eur Urol 2010; Epub ahead Oct 7.
  • Kreiner B, Denzinger S, Ganzer R, Fritsche HM, Burger M, Wieland W, Otto W. Neuroendocrine carcinoma of the seminal vesicles presenting with Lambert Eaton synrome: a case report. J Med Case rep. 2010 Oct 12;4:320.
  • Ganzer R, Robertson CN, Ward JF, Brown SC, Conti GN, Murat FJ, Pasticier G, Rebillard X, Thuroff S, Wieland WF, Blana A. Correlation of prostate-specific antigen nadir and biochemical failure after high-intensity focused ultrasound of localized prostate cancer based on the Stuttgart failure criteria - analysis from the @-Registry. BJU Int. 2011 Feb 18.
  • Ganzer R, Brandtner A, Wieland WF, Fritsche HM. Prospective blinded comparison of real-time sonoelastography targeted versus randomised biopsy of the prostate in the primary and re-biopsy setting. World J Urol. 2011 Apr 26.
  • Jung EM, Wiggermann P, Greis C, Eder F, Ehrich J, Jung W, Schreyer AG, Strosczynski C, Ganzer R. First results of endocavity evaluation of the microvascularization of malignant prostate tumors using contrast enthanced ultrasound (CEUS) including perfusion analysis: first results. Clin. Hemorheol Microcirc. 2012; 52(2-4): 167-77.
  • Walter B, Weiss T, Hofstädter F, Gaumann A, Hartmann A, Rogenhofer S, Ganzer R, Wach S, Engehausen D, Wieland WF, Blana A. Utility of immunohistochemistry markers in the interpretation of post-high-intensity focussed ultrasound prostate biopsy cores. World J Urol. 2012 Feb 19.
  • Baumunk D, Cash H, Ebbing J, Porsch M, Janitzky A, Wendler JJ, Liehr U, Ganzer R, Blana A, Schostak M. HIFU in salvage treatment of patients with prostate cancer after primary external radiation therapy – status 2012. Aktuelle Urol. 2012 Sep; 43(5):330-6. Epub 2012 Aug 8.
  • Blana A, Robertson CN, Brown SC, Chaussy C, Crouzet S, Gelet A, Conti GN, Ganzer R, Pasticier G, Thuroff S, Ward JF. Complete high-intensity focussed ultrasound in prostate cancer: outcome from the @Registry. Prostate Cancer prostatic disease.2012 Sep; 15(3): 256-9.
  • Brummeisl W, Fritsche HM, Huber E, Wieland WF, Ganzer R. A patient with fibroepithelial polyp of the ureter – a rare condition mimicking malignancy: a case report. Case Rep Urol. 2012. Epub 2012 Dec 27.
  • Ganzer R, Stolzenburg JU, Wieland WF, Bründl J. Anatomic study of periprostatic nerve distribution: immunohistochemical differentiation of parasympathetic and sympathetic nerve fibres. Eur Urol. 2012 Dec. 62(6): 1150 – 6.
  • Baumunk D, Blana A, Ganzer R, Henkel T, Köllermann J, Roosen A, Machtens S, Salomon G, Sentker L, Witzsch U, Köhrmann KU, Schostak M. Focal prostate cancer therapy: capabilities, limitations and prospects. Urologe A. 2013 Apr;52(4):549-56.
  • Bründl J, Schneider S, Weber F, Zeman F, Wieland WF, Ganzer R. Computerized quantification and planimetry of prostatic capsular nerves in relation to adjacent prostate cancer foci. Eur Urol. 2013 Mai 7.
  • Ganzer R, Fritsche HM, Brandtner J, Bründl J, Koch D, Wieland WF, Blana A. Fourteen-year oncological and functional outcomes of high-intensity focussed ultrasound (HIFU) in localized prostate cancer. BJU Int. 2013 Aug; 112(3):322-9.
  • Ganzer R, Bründl J, Koch D, Wieland WF, Burger M, Blana A. Correlation of pretreatment clinical parameters and PSA nadir after high-intensity focussed ultrasound (HIFU) for localised prostate cancer. World J Urol. 2014 Apr 3.
  • Werner-Klein M, Proske J, Werno C, Schneider K, Hofmann HS, Rack B, Buchholz S, Ganzer R, Blana A, Seelbach-Göbel B, Nitsche U, Männel DN, Klein CA. Immune humanization of immunodeficient mice using diagnostic bone marrow aspirates from carcinoma patients. PLoS One. 2014 May 15;9(5).
  • Ganzer R, Roosen A, Hadaschik B, Köllermann J, Blana A, Henkel T, Liehr AB, Baumunk D, Machtens S, Salomon G, Sentker L, Witsch U, Köhrmann KU, Schostak M;Arbeitskreis für Fokale und Mikrotherapie der Akademie der Deutschen Gesellschaft für Urologie e.V. Focal therapy for prostate cancer in Germany - 2014 status. Urologe A. 2014 Jul;53(7):1040-5.
  • Ganzer R, Stolzenburg JU, Neuhaus J, Weber F, Fuchshofer R, Burger M, Bründl J. Anatomical study of pelvic nerves in relation to seminal vesicles, prostate and urethral sphincter: immunohistochemical staining, computerised planimetry and three-dimensional reconstruction. J Urol. 2014 Oct 6.
  • Ganzer R, Stolzenburg JU, Neuhaus J, Weber F, Burger M, Bründl J. Is the striated urethral sphincter at risk by standard suture ligation of the dorsal vascular complex in radical prostatectomy? An anatomic study. Urology. 2014 Dec;84(6):1453-60.
  • Gužvić M, Braun B, Ganzer R, Burger M, Nerlich M, Winkler S, Werner-Klein M, Czyż ZT, Polzer B, Klein CA. Combined genome and transcriptome analysis of single disseminated cancer cells from bone marrow of prostate cancer patients reveals unexpected transcriptomes. Cancer Res. 2014 Dec 15;74(24):7383-94.
  • Ganzer R, Anding R, Neuhaus J, Stolzenburg JU, Anatomie des männlichen Kontinenzmechanismus in: Die Urologie Springer Verlag, Berlin-Heidelberg, 2015. 978-3-642-39940-4
  • Ganzer R, HIFU als fokale Therapie in: Alternative operative Therapie in der Uroonkologie. Springer-Verlag, Berlin-Heidelberg, 2015. 978-3-662-44419-1
  • Ganzer R, How to Create Evidence for Focal PCa Therapy Research? HIFU Focal Hemiablation as Non-invasive Therapeutic Option in: Focal Therapy of Prostate Cancer - An Emerging Strategy for Minimally Invasive, Staged Treatment. Springer-Verlag, Berlin-Heidelberg, 2015. 10.1007/978-3-319-14160-2.
  • Schostak M, Köllermann J, Hadaschik B, Blana A, Ganzer R, Henkel T, Köhrmann KU, Liehr UB, Machtens S, Roosen A, Salomon G, Sentker L, Witzsch U, Schlemmer HP, Baumunk D. Cancer control in focus insights and future perspectives for the focal treatment of prostate cancer. Aktuelle Urol. 2015 Jan;46(1):39-44.
  • Ganzer R, Do M, Rai BP, Dietel A, Stolzenburg JU. Laparoscopic radical prostatectomy. Urologe A. 2015 Feb;54(2):172-7.
  • Karl A, Buchner A, Tympner C, Kirchner T, Ganswindt U, Belka C, Ganzer R, Burger M, Eder F, Hofstädter F, Schilling D, Sievert K, Stenzl A, Scharpf M, Fend F, Vom Dorp F, Rübben H, Schmid K, Porres-Knoblauch D, Heidenreich A, Hangarter B, Knüchel-Clarke R, Rogenhofer M, Wullich B, Hartmann A, Comploj E, Pycha A, Hanspeter E, Pehrke D, Sauter G, Graefen M, Stief C, Haese A. The natural course of pT2 prostate cancer with positive surgical margin: predicting biochemical recurrence. World J Urol. 2015 Feb 15
  • Ahmed K, Brunckhorst O, Khan MS, Do M, Ganzer R, Murphy DG, Van Rij S, Dundee PE, Dasgupta P. Training in minimally invasive surgery in urology EAU-ICUD consultation.van der Poel H, Brinkman W, van Cleynenbreugel B, Kallidonis P, Stolzenburg JU, Liatsikos BJU Int. 2015 Sep 9. doi: 10.1111/bju.13320.
  • Ganzer R, Franz T, Rai BP, Siemer S, Stolzenburg J.U. Management of ureteral strictures and hydronephrosis Urologe A. 2015 Sep.
  • Wendler JJ, Friebe B, Baumunk D, Blana A, Franiel T, Ganzer R, Hadaschik B, Henkel T, Köhrmann KU, Köllermann J, Kuru T, Machtens S, Roosen A, Salomon G, Schlemmer HP, Sentker L, Witzsch U, Liehr UB, Ricke J, Schostak M. [Focal therapy for small renal masses Observation, ablation or surgery]. Urologe A. 2016 May;55(5):594-606.
  • Hau HM, Thalmann F, Lübbert C, Morgul MH, Schmelzle M, Atanasov G, Benzing C, Lange U, Ascherl R, Ganzer R, Uhlmann D, Tautenhahn HM, Wiltberger G, Bartels M. The value of hepatic resection in metastasic renal cancer in the Era of Tyrosinkinase Inhibitor Therapy. BMC Surg. 2016 Jul 22;16(1):49.
  • Stolzenburg JU, Rai BP, Do M, Dietel A, Liatsikos E, Ganzer R, Qazi H, Meneses AD, Kallidonis P. Robot-assisted technique for Boari flap ureteric reimplantation: replicating the techniques of open surgery in robotics. BJU Int. 2016 Sep;118(3):482-4.
  • Good DW, Wood A, Stewart L, Stolzenburg JU, Ganzer R, Neuhaus J, Stewart GD, McNeill SA. Striated Muscle in Radical Prostatectomy Specimens: A Marker of Apical Dissection Quality and an Independent Predictor of Urinary Continence after Endoscopic Extraperitoneal Radical Prostatectomy. Urol Int. 2017;98(1):71-78.
  • Ganzer R, Stolzenburg JU. [Open versus robot-assisted radical prostatectomy]. Urologe A. 2017 Jan;56(1):65-66.
  • Wendler JJ, Ganzer R, Hadaschik B, Blana A, Henkel T, Köhrmann KU, Machtens S, Roosen A, Salomon G, Sentker L, Witzsch U, Schlemmer HP, Baumunk D, Köllermann J, Schostak M, Liehr UB. Why we should not routinely apply irreversible electroporation as an alternative curative treatment modality for localized prostate cancer at this stage. World J Urol. 2017 Jan;35(1):11-20.
  • Franz T, von Hardenberg J, Blana A, Cash H, Baumunk D, Salomon G, Hadaschik B, Henkel T, Herrmann J, Kahmann F, Köhrmann KU, Köllermann J, Kruck S, Liehr UB, Machtens S, Peters I, Radtke JP, Roosen A, Schlemmer HP, Sentker L, Wendler JJ, Witzsch U, Stolzenburg JU, Schostak M, Ganzer R. [MRI/TRUS fusion-guided prostate biopsy : Value in the context of focal therapy]. Urologe A. 2017 Feb;56(2):208-216.
  • Gawlitza J, Reiss-Zimmermann M, Thörmer G, Schaudinn A, Linder N, Garnov N, Horn LC, Minh DH, Ganzer R, Stolzenburg JU, Kahn T, Moche M, Busse H. Impact of the use of an endorectal coil for 3 T prostate MRI on image quality and cancer detection rate. Sci Rep. 2017 Feb 1;7:40640.
  • Sieger N, Kyriazis I, Schaudinn A, Kallidonis P, Neuhaus J, Liatsikos EN, Ganzer R, Stolzenburg JU. Acute focal bacterial nephritis is associated with invasive diagnostic procedures - a cohort of 138 cases extracted through a systematic review. BMC Infect Dis. 2017 Apr 4;17(1):240.
  • Neuhaus J, Schiffer E, Mannello F, Horn LC, Ganzer R, Stolzenburg JU. Protease Expression Levels in Prostate Cancer Tissue Can Explain Prostate Cancer-Associated Seminal Biomarkers-An Explorative Concept Study. Int J Mol Sci. 2017 May 4;18(5).
  • Crouzet S, Blana A, Murat FJ, Pasticier G, Brown SCW, Conti GN, Ganzer R, Chapet O, Gelet A, Chaussy CG, Robertson CN, Thuroff S, Ward JF. Salvage high-intensity focused ultrasound (HIFU) for locally recurrent prostate cancer after failed radiation therapy: Multi-institutional analysis of 418 patients. BJU Int. 2017 Jun;119(6):896-904.
  • Ganzer R. [High intensity focused ultrasound (HIFU): Importance in the treatment of prostate cancer]. Radiologe. 2017 Aug;57(8):659-664.
  • Kallidonis P, Rai BP, Qazi H, Ganzer R, Do M, Dietel A, Liatsikos E, Ghulam N, Kyriazis I, Stolzenburg JU. Critical appraisal of literature comparing minimally invasive extraperitoneal and transperitoneal radical prostatectomy: A systematic review and meta-analysis. Arab J Urol. 2017 Aug 31;15(4):267-279.
  • Wolf B, Ganzer R, Stolzenburg JU, Hentschel B, Horn LC, Höckel M. Extended mesometrial resection (EMMR): Surgical approach to the treatment of locally advanced cervical cancer based on the theory of ontogenetic cancer fields. Gynecol Oncol. 2017 Aug;146(2):292-298.
  • Ganzer R, Franiel T, Köllermann J, Kuru T, Baumunk D, Blana A, Hadaschik B, von Hardenberg J, Henkel T, Köhrmann KU, Liehr UB, Machtens S, Roosen A, Salomon G, Schlemmer HP, Sentker L, Wendler J, Witzsch U, Schostak M. [Focal therapy of prostate cancer]. Urologe A. 2017 Oct;56(10):1335-1346.
  • Yang B, Liao GQ, Wen XF, Chen WH, Cheng S, Stolzenburg JU, Ganzer R, Neuhaus J. Nuclear magnetic resonance spectroscopy as a new approach for improvement of early diagnosis and risk stratification of prostate cancer. J Zhejiang Univ Sci B. 2017 Nov.;18(11):921-933.
  • Ganzer R, Hadaschik B, Pahernik S, Koch D, Baumunk D, Kuru T, Heidenreich A, Stolzenburg JU, Schostak M, Blana A.Prospective Multicenter Phase II Study on Focal Therapy (Hemiablation) of the Prostate with High Intensity Focused Ultrasound. J Urol. 2018 Apr;199(4):983-989.
  • Steiner C, Gevaert T, Ganzer R, De Ridder D, Neuhaus J. Comparative immunohistochemical characterization of interstitial cells in the urinary bladder of human, guinea pig and pig. Histochem Cell Biol. 2018 May;149(5):491-501.
  • Ganzer R, Arthanareeswaran VKA, Ahmed HU, Cestari A, Rischmann P, Salomon G, Teber D, Liatsikos E, Stolzenburg JU, Barret E. Which technology to select for primary focal treatment of prostate cancer?-European Section of Urotechnology (ESUT) position statement. Prostate Cancer Prostatic Dis. 2018 Jun;21(2):175-186.
  • Höffkes F, Arthanareeswaran VK, Stolzenburg JU, Ganzer R. Rate of misclassification in patients undergoing radical prostatectomy but fulfilling active surveillance criteria according to the European Association of Urology (EAU) guidelines on prostate cancer. A high volume center experience. Minerva Urol Nefrol. 2018 Jul 23.

Seite teilen:

Ihre Cookie Einstellungen

Um unsere Website für Sie zu optimieren, verwenden wir Cookies. Weitere Informationen: Datenschutzerklärung Dies umfasst Cookies, die für den Betrieb unserer Website notwendig sind, sowie weitere, die wir für verbesserte Funktionen nutzen. Sie entscheiden selbst, welchen Cookie-Kategorien Sie zustimmen möchten. Bitte berücksichtigen Sie, dass Ihnen je nach Auswahl u.U. nicht mehr alle Funktionen unserer Website zur Verfügung stehen.

Diese Cookies sind für den Betrieb unserer Websites unbedingt notwendig und immer aktiviert (Session-Cookies).